Author Archives: bvghseattle

Hands-on training equips Ivoirian clinicians with the tools for fast, accurate cancer diagnosis 

In late 2019, the University Hospital Center (CHU) Treichville in Abidjan, Côte d’Ivoire began exploring the treatment of aggressive forms of breast cancer with immunotherapy. Immunotherapies are a type of targeted cancer treatment that, unlike chemotherapy and radiation, avoid harming healthy cells. Despite their enthusiasm, the CHU Treichville team was unable to proceed due toContinue reading “Hands-on training equips Ivoirian clinicians with the tools for fast, accurate cancer diagnosis “

Drug access program provides affordable medicines to Cameroon’s cancer patients

The successful treatment of most cancers relies on the use of a cocktail of drugs that are administered at precise intervals over discrete periods of time. For example, one treatment regimen for Burkitt’s lymphoma (BL) – a cancer commonly found in Africa – requires administration of seven different drugs over a period of 15 days.Continue reading “Drug access program provides affordable medicines to Cameroon’s cancer patients”

We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there

By Jennifer Dent | President & CEO, BVGH According to a recent report issued by the American Cancer Society, cancer deaths in the United States have dropped 27 percent since 1991. This is an important milestone attributable, in large part, to lower smoking rates, advances in early detection of cancers, and the development of innovative treatments. WhileContinue reading “We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there”

Global Cancer Research Investments Are Not Reaching Africa – How the African Access Initiative Is Changing the Trend.

By Jennifer Dent | President & CEO, BVGH Cancer is one of the leading causes of death worldwide, and alarmingly, both cancer incidence and mortality are on the rise in Africa. By 2040, the number of deaths in Africa due to cancer is predicted to double. In contrast, cancer mortality in the United States has fallen by 27% since 1991, thanksContinue reading “Global Cancer Research Investments Are Not Reaching Africa – How the African Access Initiative Is Changing the Trend.”